| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |